Carolinas Wealth Consulting’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,122
Closed -$550K 204
2025
Q1
$550K Sell
8,122
-400
-5% -$23.9K 0.12% 93
2024
Q4
$383K Sell
8,522
-48
-0.6% -$2.69K 0.08% 129
2024
Q3
$539K Sell
8,570
-1
-0% -$58 0.1% 104
2024
Q2
$506K Sell
8,571
-109
-1% -$6.82K 0.1% 104
2024
Q1
$692K Buy
8,680
+8,164
+1,582% +$624K 0.14% 80
2023
Q4
$40.7K Buy
516
+20
+4% +$1.42K 0.01% 365
2023
Q3
$34.5K Sell
496
-380
-43% -$26.9K 0.01% 357
2023
Q2
$60.5K Sell
876
-21
-2% -$1.49K 0.01% 320
2023
Q1
$66.7K Sell
897
-359
-29% -$30.1K 0.01% 318
2022
Q4
$117K Buy
1,256
+152
+14% +$14.7K 0.03% 241
2022
Q3
$105K Sell
1,104
-333
-23% -$33K 0.03% 234
2022
Q2
$133K Sell
1,437
-17
-1% -$1.66K 0.03% 203
2022
Q1
$147K Sell
1,454
-298
-17% -$31.3K 0.03% 209
2021
Q4
$181K Buy
1,752
+301
+21% +$27.8K 0.04% 186
2021
Q3
$123K Sell
1,451
-589
-29% -$49.3K 0.03% 216
2021
Q2
$170K Sell
2,040
-12
-0.6% -$983 0.04% 190
2021
Q1
$154K Buy
2,052
+468
+30% +$34.1K 0.04% 200
2020
Q4
$108K Buy
1,584
+928
+141% +$60.4K 0.03% 221
2020
Q3
$38K Buy
656
+572
+681% +$35.6K 0.01% 314
2020
Q2
$5K Buy
+84
New +$5.29K ﹤0.01% 393

Other funds holding CVS

Carolinas Wealth Consulting's CVS Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of CVS Health (CVS) in Q2 2025, closing a stake of 8,122 shares — an estimated $550K sold.

Carolinas Wealth Consulting first reported a position in CVS in Q2 2020 and held it in 20 quarters. The position peaked at $692K in Q1 2024. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 8,122 CVS Health shares in Q2 2025, an estimated $550K.
  • Carolinas Wealth Consulting first reported a position in CVS Health in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's CVS Health position peaked at $692K in Q1 2024.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.